Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
The Potential Roles of Aquaporin 4 in Alzheimer's Disease.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
Evaluation of an Expanded Disability Status Scale (EDSS) modeling strategy in multiple sclerosis.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): a single case report follow-up study.
Bisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain.
CRYAB-650 C>G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
Regulatory B Cells and Mechanisms.
Migraine Headaches And Pain With Neuropathic Characteristics: Comorbid Conditions In Patients With Multiple Sclerosis.
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis.
Multiple sclerosis and pregnancy prescriptions.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.
Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis.
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
Caregiver burden in multiple sclerosis: A structured review of the instruments.

Pages